Logo image
Preoperative Gabapentin for Minimally Invasive Hysterectomy: A Randomized Controlled Trial
Journal article   Peer reviewed

Preoperative Gabapentin for Minimally Invasive Hysterectomy: A Randomized Controlled Trial

Terri Q Huynh, Nima R Patel, Neal D Goldstein and Gretchen E Makai
Journal of minimally invasive gynecology, v 28(2), pp 237-244
Feb 2021
PMID: 32389735

Abstract

Acetaminophen - administration & dosage Adult Aged Analgesics, Opioid - administration & dosage Celecoxib - administration & dosage Double-Blind Method Drug Administration Schedule Drug Therapy, Combination Enhanced Recovery After Surgery Female Gabapentin - administration & dosage Humans Hysterectomy - adverse effects Hysterectomy - methods Middle Aged Minimally Invasive Surgical Procedures - adverse effects Minimally Invasive Surgical Procedures - methods Narcotics - administration & dosage Pain Measurement Pain, Postoperative - prevention & control Preoperative Period Uterine Diseases - surgery
To evaluate whether a single dose of gabapentin given preoperatively reduces narcotic use 24 hours after minimally invasive hysterectomy (MIH). Randomized controlled trial. Single academic-affiliated community hospital. Women undergoing MIH for benign indications between June 2016 and June 2017. Subjects were randomized to receive a preoperative regimen of acetaminophen, celecoxib, and gabapentin versus acetaminophen and celecoxib alone. The primary outcome assessed was the total amount of narcotics used at 24 hours after surgery. Secondary outcomes included adverse effects from gabapentin use, total narcotics used, and pain scores at 2 weeks after surgery. A total of 129 women were randomized and eligible for analysis in the gabapentin study arm (n = 68) or the control arm (n = 61). Demographic characteristics and surgical details were similar between groups. Narcotics used at 24 hours after surgery totaling 168 versus 161 oral morphine milligram equivalents in the gabapentin and control groups, respectively, did not significantly differ between groups (p = .60). Total narcotics used and pain scores at 2 weeks after surgery and the rates of adverse effects from gabapentin were also similar between study arms. Single-dose, preoperative gabapentin for women undergoing benign MIH does not reduce total opioid use 24 hours after surgery.

Metrics

2 Record Views
5 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Obstetrics & Gynecology
Logo image